Conferences
ASTRO 2024: Precision in Practice: Optimizing Prostate Radiation with MRI-Defined Microboost
September 29, 2024
ASTRO 2024: SABR for Primary RCC – Is It Ready for Primetime?
September 29, 2024
ASTRO 2024: Radiotherapy of the Primary Tumor and All Metastatic Lesions in Oligometastatic Prostate Cancer: 5-Year Results of Prolong Study
September 29, 2024
IBCN 2024: Mechanisms of Resistance to Antibody Drug Conjugates
September 21, 2024
IBCN 2024: Systematic Evaluation of Differentially Expressed Genes Associated with Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
September 21, 2024
IBCN 2024: Spatial Proteomics and Transcriptomics Reveal an Altered Immune Cell Landscape in Bladder Cancer Patients Unresponsive to BCG Treatment
September 21, 2024
IBCN 2024: Molecular Subtypes and Outcomes in the VESPER Trial
September 21, 2024
IBCN 2024: Molecular Subtyping in 2024: The LUMBER-NAC Trial
September 21, 2024
IBCN 2024: GUSTO Trial
September 21, 2024
IBCN 2024: ADC Toxicity, Management and Clinical Trial Updates
September 21, 2024
IBCN 2024: Benefit of Whole-Pelvis Radiation for Patients with Muscle Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis
September 21, 2024
IBCN 2024: Influence of Immortal Time Bias and Conditional Survival on the Comparison of Radical Cystectomy Versus Trimodality Therapy for Muscle Invasive Bladder Cancer
September 21, 2024
IBCN 2024: Using Urinary Genomic Disease Burden to Assess Cretostimogene Grenadenorepvec: Preliminary Analysis from the BOND-003 Trial
September 21, 2024
IBCN 2024: Augmented Cystoscopy with Deep Learning
September 21, 2024